• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AGA MEDICAL CORPORATION AMPLATZER MUSCULAR VSD OCCLUDER; CARDIAC OCCLUSION DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AGA MEDICAL CORPORATION AMPLATZER MUSCULAR VSD OCCLUDER; CARDIAC OCCLUSION DEVICE Back to Search Results
Model Number 9-VSD-MUSC-010
Device Problems Migration or Expulsion of Device (1395); Difficult to Remove (1528)
Patient Problems Embolism (1829); Low Blood Pressure/ Hypotension (1914)
Event Date 06/05/2014
Event Type  Injury  
Event Description
Due to the patient's large patent ductus arteriosus (pda), a 10mm amplatzer muscular vsd occluder (muscvsd) was implanted.After the muscvsd was deployed, a wiggle test and fluoroscopy confirmed satisfactory device placement, so the device was released.The patient was hemodynamically stable and the patient was released to the post-anesthesia recovery unit.Approximately two hours later, the patient's diastolic pressure dropped 30 points and an x-ray determined the muscvsd device had embolized to the right pulmonary artery.Percutaneous retrieval was unsuccessful despite attempts for three hours using various retrieval devices.The patient was referred for surgery where the muscvsd was explanted the same day and pda was surgically repaired.The patient was reportedly stable the next day.
 
Manufacturer Narrative
The 10mm muscvsd was returned to sjm and decontaminated.The occluder was grossly and microscopically examined, and no anomalies were found.The muscvsd met dimensional specifications when measured with a caliper.The occluder was loaded into a test loader, deployed and retracted without difficulty or deformation, under non-physiological conditions.The device history record for this product was reviewed to ensure that each manufacturing and inspection operation was performed.The review determined the process was performed and completed in accordance with sjm specifications and procedures.The results of this investigation confirmed the muscvsd met all functional and dimensional specifications when analyzed at sjm.There was no evidence to suggest there was an intrinsic defect in the occluder, and the cause of the embolization remains unknown.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AMPLATZER MUSCULAR VSD OCCLUDER
Type of Device
CARDIAC OCCLUSION DEVICE
Manufacturer (Section D)
AGA MEDICAL CORPORATION
5050 nathan lane north
plymouth MN 55442
Manufacturer (Section G)
AGA MEDICAL CORPORATION
5050 nathan lane north
plymouth MN 55442
Manufacturer Contact
denise johnson
5050 nathan lane north
plymouth, MN 55442
6517565400
MDR Report Key3900450
MDR Text Key4674651
Report Number2135147-2014-00061
Device Sequence Number1
Product Code MLV
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P040040
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 06/05/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Physician
Device Expiration Date01/31/2019
Device Model Number9-VSD-MUSC-010
Device Lot Number4506206
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer06/13/2014
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 06/05/2014
Initial Date FDA Received06/27/2014
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured03/10/2014
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age17 YR
-
-